785 articles
A 24-year-old took tejocote root pills and nearly died. The culprit: toxic yellow oleander hidden in mislabeled supplements.
A 20-year study finds severe diabetic retinopathy plummeted dramatically, crediting better diabetes drugs and improved screening.
A Danish RCT finds semaglutide dramatically reduces heavy drinking days and cravings in adults with obesity and alcohol use disorder.
A new meta-analysis finds 30% of pure autonomic failure patients develop Parkinson's or related disorders within 6 years — a major early warning signal.
A major European trial finds colonoscopy reduces colorectal cancer incidence but shows no statistically significant drop in mortality, thanks to better treatments.
New wearable and non-invasive glucose monitors are transforming diabetes care — here's what's available and how they work.
NYU researchers found accelerated aging in monocytes links to emotional depression symptoms, moving toward an objective blood-based diagnostic.
OpenAI's o1-preview outperformed physicians on complex clinical cases, raising the bar for AI-assisted medicine.
Scribe Therapeutics unveils STX-1150, a liver-targeted epigenetic therapy that durably lowers LDL cholesterol with one dose and no permanent DNA edits.
Aspen Neuroscience's stem cell therapy restored dopamine neurons in Parkinson's patients, adding ~2 hours of controlled movement daily.
New research reveals sugar pushes skin cells into senescence and slows repair, linking diet directly to accelerated skin and systemic aging.
New Phase 2/3 trial data show buntanetap improved cognition in early-stage Alzheimer's patients positive for pTau217, hinting at disease-modifying effects.
